image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Cohort - In-year order intake 1.3x turnover

February 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CHRT
  • Price:
  • 550p
To paraphrase an old saying “there are decades in which nothing happens and weeks in which decades happen” and 2023 was very much an example of the latter. It began with tentative hopes that Ukraine’s long-planned counter offensive might force a quick end to Russian hostilities but not only did those hopes evaporate but a new crisis erupted in Gaza and is now preventing commercial shipping from using the Red Sea (for fear of attack from Iranian backed Houthi rebels in Yemen) in spite of the US Navy intercepting cheap drones with US$1m missiles. Meanwhile, there’s been  an up-tick in Communist Chinese warships and aircraft encroaching into the Taiwanese Strait weeks ahead of the latter’s democratic elections. As the odds on a catas ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author